IPP Bureau
Thermo Fisher Scientific deploys cryo-transmission electron microscope at CCMB, Hyderabad
By IPP Bureau - April 12, 2022
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Healthcare Venture’s Wavemaker360 appoints Monica Jain as new partner
By IPP Bureau - April 12, 2022
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
By IPP Bureau - April 12, 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Cambrex completes large-scale US API expansion
By IPP Bureau - April 12, 2022
The expansion positions Cambrex with the largest and most advanced API facility in the United States
New very-high-sensitivity rapid antigen test kits hit Australian market
By IPP Bureau - April 11, 2022
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
Glenmark Specialty receives DCGI approval for Phase 1 clinical trial of its novel molecule
By IPP Bureau - April 11, 2022
GRC 54276 has shown tumour cell killing ability in preclinical studies as a single agent and as well in combination with checkpoint inhibitors, making it a high-priority target in immuno-oncology
Crosscope collaborates with Waleed Pharmacy to enter Oman
By IPP Bureau - April 11, 2022
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
By IPP Bureau - April 11, 2022
Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones
Honeywell teams with AstraZeneca to develop net-gen inhalers to combat global warming
By IPP Bureau - April 11, 2022
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
By IPP Bureau - April 11, 2022
These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection
Intuitive launches My Intuitive App
By IPP Bureau - April 11, 2022
The app serves as a single, integrated, personalized customer platform for da Vinci surgeons
Israel’s TAU breakthrough offers new hope to help people with paralysis walk again
By IPP Bureau - April 11, 2022
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
BMSF names diversity in clinical trials training program after Robert A Winn
By IPP Bureau - April 11, 2022
The groundbreaking, uniquely robust Robert A. Winn Diversity in Clinical Trials Award Program is on track to train more than 500 individuals from diverse backgrounds by 2027
Global pharma back Turn Biotechnologies to advance its cell rejuvenation program
By IPP Bureau - April 11, 2022
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
Lonza signs manufacturing deal with Asher Biotherapeutics
By IPP Bureau - April 11, 2022
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
